Xuan Wu

4.4k total citations
142 papers, 2.8k citations indexed

About

Xuan Wu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuan Wu has authored 142 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 43 papers in Oncology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuan Wu's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (10 papers) and Neuroscience and Neuropharmacology Research (8 papers). Xuan Wu is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (10 papers) and Neuroscience and Neuropharmacology Research (8 papers). Xuan Wu collaborates with scholars based in China, United States and Canada. Xuan Wu's co-authors include Ann M. Marini, Robert H. Lipsky, Wenhua Liang, Jingxun Wu, Han‐Xiang An, Wenfeng Fang, Zhihuang Hu, Zhenkui Pan, Feng Ye and Daming Zhu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Blood.

In The Last Decade

Xuan Wu

128 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuan Wu China 32 959 819 595 390 349 142 2.8k
Marzenna Podhorska‐Okołów Poland 31 1.5k 1.5× 842 1.0× 512 0.9× 576 1.5× 276 0.8× 177 3.3k
Ming Jiang China 29 1.3k 1.3× 527 0.6× 546 0.9× 409 1.0× 200 0.6× 101 2.6k
Hyung-Seok Kim South Korea 31 1.3k 1.4× 396 0.5× 281 0.5× 309 0.8× 221 0.6× 156 3.2k
Li Cai China 32 1.7k 1.8× 807 1.0× 524 0.9× 802 2.1× 323 0.9× 159 3.3k
Lingbin Meng United States 26 1.3k 1.3× 427 0.5× 462 0.8× 338 0.9× 326 0.9× 74 2.8k
Yu Cao China 27 1.3k 1.4× 371 0.5× 272 0.5× 545 1.4× 264 0.8× 109 2.5k
Shozo Nishida Japan 36 1.6k 1.6× 974 1.2× 366 0.6× 727 1.9× 250 0.7× 171 3.6k
Nickolai O. Dulin United States 38 2.3k 2.4× 460 0.6× 634 1.1× 330 0.8× 407 1.2× 98 3.9k
Tao Zeng China 30 1.1k 1.2× 274 0.3× 678 1.1× 519 1.3× 308 0.9× 151 2.6k

Countries citing papers authored by Xuan Wu

Since Specialization
Citations

This map shows the geographic impact of Xuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Wu more than expected).

Fields of papers citing papers by Xuan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Wu. The network helps show where Xuan Wu may publish in the future.

Co-authorship network of co-authors of Xuan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan Wu. A scholar is included among the top collaborators of Xuan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan Wu. Xuan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yajun, Man Chen, Shiwei Wang, et al.. (2025). Structural and molecular dysfunctions in granulosa cells: A key contributor to porcine follicular atresia. Reproductive Biology. 25(2). 101008–101008.
2.
Wang, Shuai, Yongsen Wang, Xuan Wu, Yang Li, & Xiaoju Zhang. (2025). Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy. World Journal of Surgical Oncology. 23(1). 34–34. 2 indexed citations
3.
Wu, Xuan, et al.. (2025). How Prosocial Modeling Promotes Children's Sharing: A Goal Contagion Account. Developmental Science. 28(3). e70020–e70020.
4.
Zhou, Ying, Xuan Wu, Ping Zhu, & Wenhua Zhang. (2025). Single-Atom Catalysts for CO2 Reduction to Oxalate: Theoretical Design and Reaction Condition Prediction. ACS Applied Materials & Interfaces. 17(35). 49564–49572.
6.
Tan, Lunbo, Zhou Liu, Hong Liu, et al.. (2025). Metabolic Profiles of Pregnancy With Polycystic Ovary Syndrome: Insights into Maternal-Fetal Metabolic Communication. The Journal of Clinical Endocrinology & Metabolism. 110(6). 1524–1536. 2 indexed citations
7.
Wu, Xuan, Ming Liu, Xiaohuan Sun, et al.. (2024). In situ supramolecular self-assembly of a perylene diimide derivative in mitochondria for cancer cell ferroptosis. Organic Chemistry Frontiers. 11(21). 6055–6063. 4 indexed citations
8.
He, Min, Yuwei Wang, Jiabin Cai, et al.. (2024). Robot-assisted resection of renal tumor in children and comparison with laparoscopic surgery. BMC Surgery. 24(1). 325–325. 1 indexed citations
9.
Cheng, Boran, Lei Cao, Chen Li, et al.. (2023). Fluorine-doped carbon quantum dots with deep-red emission for hypochlorite determination and cancer cell imaging. Chinese Chemical Letters. 35(6). 108969–108969. 29 indexed citations
10.
Huang, Ruofan, Jian Liu, Xiaochen Zhang, et al.. (2023). Modulating MDSCs by HF1K16: A mono-therapy phase Ia study examining safety and preliminary efficacy in patients with refractory and metastatic cancer.. Journal of Clinical Oncology. 41(16_suppl). e14040–e14040. 1 indexed citations
11.
Li, Yang, Xinxin Fan, Chao Zhou, et al.. (2023). Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma. Translational Lung Cancer Research. 12(8). 1766–1781. 7 indexed citations
12.
Zhang, Ling, Wei Zhang, Xuan Wu, et al.. (2023). A sex- and site-specific relationship between body mass index and osteoarthritis: evidence from observational and genetic analyses. Osteoarthritis and Cartilage. 31(6). 819–828. 13 indexed citations
13.
Li, Baocun, Xuan Wu, Yuxin Zhang, et al.. (2023). A NOVEL IMMUNOSTIMULATORY PD-L1/OX40 TETRAVALENT BISPECIFIC ANTIBODY FOR CANCER IMMUNOTHERAPY. PubMed Central. 6(Supplement_1). 2 indexed citations
15.
Zhu, Min, et al.. (2023). POP1 promotes the progression of breast cancer through maintaining telomere integrity. Carcinogenesis. 44(3). 252–262. 2 indexed citations
16.
Bai, Ruijun, Michael Z. Miao, Hui Li, et al.. (2022). Increased Wnt/β-catenin signaling contributes to autophagy inhibition resulting from a dietary magnesium deficiency in injury-induced osteoarthritis. Arthritis Research & Therapy. 24(1). 165–165. 18 indexed citations
17.
Yang, Xiao, et al.. (2021). [Bax inhibitor-1 inhibits calcification of vascular smooth muscle cells in vitro].. PubMed Central. 1 indexed citations
18.
Zhao, Hui, et al.. (2017). Association Between ADRB2 Genetic Polymorphisms and the Risk of Chronic Obstructive Pulmonary Disease: A Case-Control Study in a Chinese Population. Genetic Testing and Molecular Biomarkers. 21(8). 491–496. 5 indexed citations
19.
Ma, Yuxiang, Yunpeng Yang, Yan Huang, et al.. (2014). An investigation of symptom burden and quality of life in Chinese chemo-naïve advanced lung cancer patients by using the Instrument-Cloud QOL System. Lung Cancer. 84(3). 301–306. 10 indexed citations
20.
Marini, Ann M., Hong Jiang, Hongna Pan, Xuan Wu, & Robert H. Lipsky. (2007). Hormesis: A promising strategy to sustain endogenous neuronal survival pathways against neurodegenerative disorders. Ageing Research Reviews. 7(1). 21–33. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026